Nyxoah (NYXH) EBITDA Margin Growth (1y) (2022 - 2026)
Nyxoah (NYXH) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -321.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -658.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -315.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 192.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 563.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -331.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2,844.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 26.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -495.00 |
| 10 | Nyxoah | 0.69 | 0.69 | 4.26 Mn | -638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -638.00 |
| Dec 31, 2025 | -46.01 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | -25,005.00 |
| Mar 31, 2025 | -107.87 Mn |
| Dec 31, 2024 | 218.29 Mn |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 64,305.00 |
| Mar 31, 2024 | -265.38 Bn |
| Dec 31, 2023 | -213.82 Mn |
| Sep 30, 2023 | -374,489.00 |
| Jun 30, 2023 | 29,787.00 |
| Mar 31, 2023 | 265.49 Bn |
| Dec 31, 2022 | -2.88 Bn |
| Sep 30, 2022 | 99,475.00 |
| Jun 30, 2022 | 456,907.00 |